EIFFEL BIOTECH CO., LTD.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Eiffel Biotech’s flagship product is its proprietary high‑activity nattokinase (BSNK66®), with activity up to 50,000 FU/g. This enzyme has been experimentally shown to dissolve clots, lower blood pressure, and prevent atherosclerosis. The company also off
The content above was translated by Ai
Founded Year
2011
Unified Business No.
53503311
Status
Active
Number of Employees
0
Total Paid-in
Capital
10,000,000 (NT$)
Location of Company
Taiwan
, Yunlin County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Eiffel Biotech is a Taiwan‑based specialist manufacturer of nattokinase. Founded in 2011, the company leverages advanced equipment and strict quality control — including ISO 22000 and HACCP certifications — to supply high‑activity enzyme raw materials for global pharmaceutical and health‑food industries.
The content above was translated by Ai
